Which Cancers Are Likely to Be Genetic?
In some families, there’s an abnormal gene that gets passed from one generation to the next and that causes cancer. A person who inherits this
Kidney Cancer Treatment Options in Connecticut, Maryland, and New Jersey
The road to kidney cancer recovery looks different for every patient. At Regional Cancer Care Associates, our seasoned providers recognize these idiosyncrasies and develop personalized kidney cancer treatment plans to address them. Using a combination of state-of-the-art therapies and holistic care techniques, we help patients living throughout Connecticut, Maryland, and New Jersey lead fulfilling lives while battling cancer.
Chemotherapy
One of the most common forms of cancer treatment, chemotherapy involves using powerful drugs to attack and kill cancer cells. Often called “chemo,” our providers frequently use it to treat kidney cancer.
Immunotherapy
Our immune systems help fight off infections and other harmful diseases. Immunotherapy, a type of biological therapy, grasps onto this principle and uses substances made from living organisms to treat cancers, including kidney cancer. In this way, the immune system is “recruited” to help battle the cancer.
Targeted Therapy
When targeted therapy is used to treat kidney cancer, its goal is to eliminate cancerous cells while preserving the normal, healthy cells that surround them. To accomplish this, some forms of targeted therapy block the actions of enzymes, proteins, and more. In some cases, this method can produce fewer side effects than other forms of cancer treatment.
Radiation Therapy
Through the use of radiation therapy, oncologists can destroy or slow the growth of cancerous kidney cells with high-energy rays. Radiation therapy can be delivered externally, internally, or via radioactive drugs.
Clinical Trials
In some cases, clinical trials may offer promising treatment outcomes for patients with kidney cancer. These experimental trials are commonly used to compare an effective, known treatment for a particular type of cancer with a novel approach. These new treatments might be new drugs, a unique combination of drugs, or a different way of using an established therapy.
Genetic Testing
By genetically testing the DNA of kidney cancer cells, our care providers can learn more about the cells’ particular mutations. From there, they can develop more effective treatment plans based on each patient’s unique genetic makeup.
Palliative Care
No matter what type of cancer a patient has, our palliative care services can help manage the negative side effects associated with the disease. To help patients maintain their quality of life, our physicians may facilitate the provision of social support, bereavement counseling, and more.
Integrative Care
To deliver integrative care for kidney cancer, our clinical team provides a combination of conventional treatments and supportive therapies. While the conventional treatments attack the cancer, the supportive therapies mediate and combat side effects caused by the conventional treatments.
Complete Mind and Body Support
To support patients and further supplement their treatments, our team may also provide complete mind and body support. This can take the form of nutritional counseling, developing an appropriate exercise regimen, facilitating a patient’s participation in a yoga class, and more.
Learn More about Our Kidney Cancer Treatments
As kidney cancer is one of the most common cancer types in the United States, we’re driven to provide a wide enough range of treatment options to help as many patients as possible in Connecticut, Maryland, and New Jersey. If you or a loved one is experiencing kidney cancer symptoms or is at an elevated risk of developing the disease, schedule an evaluation at Regional Cancer Care Associates today.
RELATED ARTICLES
27 New Jersey-based RCCA physicians recognized as Top Doctors by Castle Connolly
New Jersey is home to some of the nation’s leading oncologists and hematologists, many of whom practice at Regional Cancer Care Associates (RCCA) treatment centers throughout the Garden State.
Uterine Cancer: RCCA Gynecologic Oncologist Ami Vaidya, MD, Outlines the Risk Factors and Signs You Need to Know
Uterine cancer is the most common cancer of the female reproductive system. It occurs most often in postmenopausal women in their early to mid-60s, but younger women can develop the disease, too.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.